2023 - Research.com Medicine in Belgium Leader Award
Reduced exposure to calcineurin inhibitors in renal transplantation.
Henrik Ekberg;Helio Tedesco-Silva;Alper Demirbas;Štefan Vítko.
The New England Journal of Medicine (2007)
PLACEBO-CONTROLLED STUDY OF MYCOPHENOLATE MOFETIL COMBINED WITH CYCLOSPORINE AND CORTICOSTEROIDS FOR PREVENTION OF ACUTE REJECTION
J Grinyo;C Groth;R Pichlmayr;Sa Sadek.
The Lancet (1995)
A phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study).
F. Vincenti;B. Charpentier;Y. Vanrenterghem;L. Rostaing.
American Journal of Transplantation (2010)
A randomized double-blind, multicenter plasma concentration controlled study of the safety and efficacy of oral mycophenolate mofetil for the prevention of acute rejection after kidney transplantation.
T van Gelder;L B Hilbrands;Yves Vanrenterghem;W Weimar.
Free serum concentrations of the protein-bound retention solute p-cresol predict mortality in hemodialysis patients
Bert Bammens;Pieter Evenepoel;H Keuleers;Kristin Verbeke.
Kidney International (2006)
The pharmacokinetic‐pharmacodynamic relationship for mycophenolate mofetil in renal transplantation
Michael D. Hale;Andrew J. Nicholls;Roy E.S. Bullingham;Ronald Hené.
Clinical Pharmacology & Therapeutics (1998)
Incidence, determinants, and consequences of subclinical noncompliance with immunosuppressive therapy in renal transplant recipients.
Sabina De Geest;Liesbeth Borgermans;Hilde Gemoets;Ivo Abraham;Ivo Abraham.
Prevalence and management of anemia in renal transplant recipients: a European survey
Yves Vanrenterghem;Claudio Ponticelli;José Maria Morales;Daniel Abramowicz.
American Journal of Transplantation (2003)
Sirolimus reduces the incidence of acute rejection episodes despite lower cyclosporine doses in caucasian recipients of mismatched primary renal allografts: a phase II trial. Rapamune Study Group.
Barry D. Kahan;Bruce A. Julian;Mark D. Pescovitz;Yves Vanrenterghem.
Free p-cresol is associated with cardiovascular disease in hemodialysis patients
B.K.I. Meijers;B. Bammens;B. De Moor;K. Verbeke.
Kidney International (2008)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: